Superintelligence and AI agents
~42The repeated promise of superintelligence sits beside small, product-shaped bets on bots, agents, and prompt tools.
Issue 2026-09-30470 names entered the exit market
Exit market · 2026-09-30
A share of newborn domains go directly to market. Their vocabulary records what someone thought might be valuable—even when no site was ever built.
The naming floor
Frequency among the 470 names, after splitting the domain strings into words.
Model reading
Loose groupings in the day’s sales vocabulary—not endorsements or measures of market value.
The repeated promise of superintelligence sits beside small, product-shaped bets on bots, agents, and prompt tools.
“Dot” is less a subject than a reusable naming ingredient, suggesting owners hoped a simple suffix could make any idea feel like a platform.
These names frame technology as practical infrastructure—chips, security, tools, and robots—rather than science fiction.
The wellness vocabulary sells repair and reassurance, turning ordinary care into a branded destination.
These are small claims on movement and location: a route, a region, or a dream holiday packaged as a future business.
The mix of payment language, crypto, and casinos gives speculation both a respectable suit and a conspicuous back door.
Editorial reading
The loudest bet is on intelligence: “superintelligence” recurs with almost incantatory insistence, while bots, prompts, and agents promise to make that future usable. Around it, “dot” becomes a kind of blank branding template, ready to attach itself to anything from security to offline life.
The emotional register is upbeat but thin-skinned: super, ultimate, limitless, fresh, safe. These names try to sound confident before there is a product behind them, then soften the wager with wellness, travel, and self-improvement.
What is being released is not one failed grand idea so much as a bundle of plausible beginnings—an app, a marketplace, a health brand, a crypto play. The heavy use of .com alongside a large .xyz share makes the batch feel split between conventional commercial hope and cheap, open-ended experimentation.
Address endings